News Focus
News Focus
Post# of 257382
Next 10
Followers 843
Posts 122860
Boards Moderated 9
Alias Born 09/05/2002

Re: DewDiligence post# 241284

Wednesday, 03/08/2023 10:28:37 AM

Wednesday, March 08, 2023 10:28:37 AM

Post# of 257382
OPK, MRK collaborate on Epstein-Barr vaccine—$50M up-front cash to OPK:

https://finance.yahoo.com/news/opko-health-modex-therapeutics-enters-130000637.html

OPKO Health…today announced that ModeX Therapeutics, Inc., an OPKO Health company, entered into an exclusive worldwide license and collaboration agreement with Merck…for the development of MDX-2201, ModeX’s preclinical nanoparticle vaccine candidate targeting EBV.

There is no currently no approved vaccine for EBV.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Discover What Traders Are Watching

Explore small cap ideas before they hit the headlines.

Join Today